Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT (Q44594083)
Jump to navigation
Jump to search
scientific article published on September 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT |
scientific article published on September 1, 2003 |
Statements
1 reference
Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT (English)
Arutselvan Natarajan
1 reference
Frederik Jacobs
1 reference
Sally J. DeNardo
Gerald L. DeNardo
A. Yuan
Carol M. Richman
Robert T. O'Donnell
Primo N. Lara
David L. Kukis
Kathleen R. Lamborn
Christine L. Hartmann Siantar
1 September 2003
1 reference
1 reference
9
1 reference
10 Pt 2
1 reference
3938S-44S
1 reference
Identifiers
1 reference